Genentech Gets Taiwanese Co. To Abandon Biosimilars
Taiwan's JHL Biotech has agreed to stop developing copycat versions of four Genentech biologics as part of an unfinalized deal to end high-stakes trade secrets litigation, Genentech confirmed Monday. ...To view the full article, register now.
Already a subscriber? Click here to view full article